Category Archives: Uncategorized

26 Oct

Sage Therapeutics Turned Down – Don’t Rush to Be a Buyer

Click to view a price quote on SAGE. Click to research the Drugs industry.

26 Oct

Hydropower conference: the impact of EU R&D funding – 8 November 2018, Brussels, Belgium

[Source: Research & Innovation] A hydropower research conference will take place in Brussels on 8 November 2018. The event will

26 Oct

BIO Patient & Health Advocacy Summit Concludes Today

Each year BIO brings the patient stakeholder community together for the BIO Patient and Health Advocacy Summit to network; to

26 Oct

CALL FOR PROPOSALS FOR ACTION GRANTS UNDER 2018 RIGHTS, EQUALITY AND CITIZENSHIP WORK PROGRAMME

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: REC-AG-2018Pillar: REC Programme 2014-2020Opening Date: Deadline: Thu, 27 Sep 2018 17:00:00 (Brussels local time)Modification Date: Thu, 25

26 Oct

Former Hillary Clinton Aide on Bomb Threats: ‘It’s Almost Like They’re Following Donald Trump’s …

“If you look at who they’ve targeted so far, it’s almost like they’re following Donald Trump’s Twitter feed,” said former

26 Oct

Startup Developing Opioid Alternative Takes Top ‘Quick Pitch’ Honors

The winner of the largest-ever startup pitch contest in San Diego is aiming to solve a problem that is weighing

25 Oct

Trump Plan Ties Medicare Drug Prices to Cheaper Foreign Ones

[Updated 4:15pm ET with pharma industry trade group comment, see below.] When the Trump administration announced its blueprint for lowering

25 Oct

Call for proposals for ERC Consolidator Grant

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: ERC-2019-COGPillar: Excellent ScienceOpening Date: Deadline: Thu, 7 Feb 2019 17:00:00 (Brussels local time)Modification Date: Thu, 25 Oct

25 Oct

European Scientists Unite to Safeguard Gene-Editing for Crops

Leading researchers representing more than 85 European plant and life sciences research centres and institutes have endorsed a position paper

25 Oct

Amgen Slashes Cholesterol Drug Price 60% to Match Rival Regeneron

Amgen is cutting the list price of its new cholesterol-lowering drug by nearly 60 percent, a move the company says